Pavaki Capital Management
$200M 13F equity value
140 Holdings
Quarter ended September 30, 2026
The latest 13F on file for Pavaki Capital Management covers the quarter ended September 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| NVDA | NVIDIA CORPORATION | 130,000 | $30M | 14.9% |
| CVX | CHEVRON CORP NEW | 103,000 | $21M | 10.5% |
| INTU | INTUIT | 38,600 | $11M | 5.3% |
| B | BARRICK MNG CORP | 226,500 | $9M | 4.6% |
| QCOM | QUALCOMM INC | 49,000 | $9M | 4.5% |
| REGN | REGENERON PHARMACEUTICALS | 11,300 | $9M | 4.3% |
| MIST | MILESTONE PHARMACEUTICALS IN | 9,337,848 | $8M | 4.0% |
| TXT | TEXTRON INC | 90,800 | $7M | 3.5% |
| BTG | B2GOLD CORP | 1,180,000 | $6M | 3.1% |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 187,000 | $5M | 2.5% |
Track Pavaki Capital Management's 13F portfolio: $200M in reported holdings, 140 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}